<DOC>
	<DOCNO>NCT00741104</DOCNO>
	<brief_summary>This observational study explore Swedish national population patient rheumatoid arthritis ( RA ) infliximab maintenance therapy order identify patient may eligible dose reduction study . Patients ask variety question regard treatment dose disease activity , ask whether would consider participate dose reduction study . Patients study described term demographic disease characteristic .</brief_summary>
	<brief_title>A Feasibility Study Exploring Effect Remicade Disease Activity RA Patients ( Study P05417 )</brief_title>
	<detailed_description>Already know Subjects ( RA least 12 month ongoing Remicade treatment ) clinic could participate eligible .</detailed_description>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Rheumatoid arthritis , infliximab maintenance treatment least past 12 month , give write informed consent . episodic treatment infliximab</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>